(Q37609388)

21 August 2017

title

Review of the costs of illness of ankylosing spondylitis and methodologic notes (English)

1 reference

21 August 2017

main subject

ankylosing spondylitis

1 reference

based on heuristic

inferred from title

author

Désirée van der Heijde

series ordinal

2

object named as

Désirée van der Heijde

0 references

Annelies Boonen

series ordinal

1

object named as

Annelies Boonen

1 reference

21 August 2017

language of work or name

1 reference

1 April 2005

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

21 August 2017

published in

1 reference

21 August 2017

volume

5

1 reference

21 August 2017

issue

2

1 reference

21 August 2017

page(s)

163-181

1 reference

Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.2.163

Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.2.163

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.2.163

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.2.163

Functional disability predicts total costs in patients with ankylosing spondylitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.2.163

The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.2.163

Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.2.163

Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.2.163

Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.2.163

21 January 2018

Identifiers

DOI

10.1586/14737167.5.2.163

1 reference

21 August 2017

1 reference